Articles tagged with Mucus
A nationwide Swedish study of 27,789 individuals with confirmed celiac disease found no link between antibiotic use and increased risk of developing the autoimmune disorder. The study also revealed a higher proportion of prior antibiotics used among those with normal mucosa, suggesting other factors may contribute to its development.
Researchers at PolyU have developed an acid-resistant, ultra-stable mucus-inspired hydrogel that significantly improves gastrointestinal wound healing in animals and outperforms a clinically approved mucosal protectant. The hydrogel's potential for commercialization is high due to its low cost, ease of production, and established safet...
Researchers identified mucins that defend against Salmonella and other bacteria causing diarrhea. Synthetic versions of these mucins could help prevent or treat illness in soldiers or travelers. The study suggests a low-cost solution to a major global health challenge.
Researchers developed an acid-resistant hydrogel called ultrastable mucus-inspired hydrogel (UMIH) that improved gastrointestinal wound healing in animal models and outperformed a clinically approved mucosal protectant. UMIH showed 15 times stronger adhesive abilities and remained stable for 7 days in acidic conditions.
Researchers have discovered that anemonefish have evolved to maintain very low levels of sialic acid in their skin mucus to avoid triggering the release of nematocysts in their sea anemone hosts. This adaptation allows them to safely coexist with sea anemones, which also lack these sugar compounds in their own mucus.
Researchers at TUM found that cystic fibrosis causes changes in the immune system as early as birth, leading to frequent inflammation and infections. These changes are not affected by CFTR modulator therapies.
Researchers investigated ozonated water's impact on SARS-CoV-2 in saliva, discovering that protein concentrations like amylase and mucin decrease ozone stability and effectiveness. This study provides insights into the applicability of ozonated water for disinfection in real-world settings.
A comprehensive study reveals that Akkermansia muciniphila breaks down sugars locked in mucus using a set of enzymes. The findings provide new insights into the molecular mechanisms behind this process and its potential applications in understanding disease and improving gut health.
Scientists discover bacterial cells forming cable-like structures that intertwine like living gels. The cables, found to be thousands of cells long, continue to grow as long as the cells have nutrients.
A team of researchers at Vanderbilt University has developed robotic sensory cilia that can monitor mucus conditions in human airways, detecting infection, obstruction, and disease severity. The technology leverages external magnetic fields to sense mucus viscosity and layer thickness, paving the way for real-time monitoring and early ...
Researchers found that reducing sialic acid levels on MUC5B mucin protein can alter its structure, leading to entangled polymers and impaired mucus transport. This study identifies a possible therapeutic strategy for treating cystic fibrosis and other muco-obstructive diseases.
Repeated antibiotic use can cause defects in the gut's protective mucus barrier, even months after treatment. This is due to changes in the microbiota or direct effects of antibiotics on the mucus layer. The findings suggest that antibiotics should be used responsibly to prevent long-lasting damage.
A new study published in Science Advances has found that antibiotics disrupt the protective mucus layer in the intestine, increasing the risk of inflammatory bowel disease. Researchers discovered that antibiotics damage the mucus barrier in a microbiota-independent manner, facilitating bacterial penetration and gut inflammation.
Researchers at the University of Virginia School of Engineering and Applied Science have designed a drug-carrying molecule that can slip past the lung's natural defenses. The nanocarrier, called PEG-BB, is shaped like a bottlebrush and mimics the properties of mucus, allowing it to move quickly through the airway.
A research team has identified novel biomarkers in cervical mucus samples that show high diagnostic power for detecting cervical cancer. The findings suggest that analyzing local expression levels may offer a superior diagnostic strategy, potentially reducing the need for invasive procedures.
A study found that dogs with a gallbladder disease similar to human cystic fibrosis have impaired CFTR function, not a genetic mutation. This discovery could lead to new treatment targets and insights into the underlying causes of CF-like diseases.
A recent observational study shows that the new treatment significantly improves the health status of school-aged children with cystic fibrosis. The results, published in the European Respiratory Journal, have been a game-changer for most patients.
A study found that low doses of filtered kretek cigarette smoke altered rat lung histometric measurements, increasing the size of respiratory bronchioles. P53 gene overexpression was also observed in response to exposure. The findings suggest potential health risks from even low levels of kretek cigarette smoke.
A team of researchers created a microfluidic human cervix model that replicates the complex interactions between cervical epithelial cells, mucus production, and microbiome. The Cervix Chip technology offers a new testbed for bacterial vaginosis therapeutics and other treatments, addressing a key women's health gap.
Researchers developed a system to grow mucus-producing intestinal cells for in vitro testing, allowing for the exploration of mucus behavior under different conditions. The platform simulates infections and tests drug effects on mucus without affecting its properties.
Scientists at DTU and Lund University have found new enzymes that can remove both the A and B blood antigens and their blocking sugars, enabling the production of universal donor blood. This breakthrough has the potential to reduce logistics and costs associated with storing four different blood types.
Researchers found a link between low fiber diets, mucin-degrading bacteria, and increased inflammation in mice with IBD genetics. A high-fiber diet prevented inflammation and even reversed symptoms in some cases.
Scientists synthesized major component of mucus and discovered that altering healthy cell mucins made them act more like cancer cells. Researchers created synthetic mucins to study their impact on cancer biology, finding a potential target for cancer treatments.
Researchers at Cold Spring Harbor Laboratory have uncovered a mechanism involved in pancreatic cancer transformation, discovering that low-grade pancreatic cancer cells depend on mucus to survive and thrive. This knowledge could help set the stage for future diagnostic or therapeutic strategies.
Researchers at UBC Okanagan have discovered a way to study MUC2, a critical gut protein, from fecal matter, providing a non-invasive method for monitoring gut health. This breakthrough could lead to significant advancements in managing and preventing gut-related diseases.
Cadmium exposure from cigarette smoke can lead to increased ANO1 expression in airway epithelial cells, exacerbating COPD. MicroRNA-381 negatively regulates ANO1, but its downregulation by cadmium could worsen disease severity.
Researchers found that thicker mucus enhances bacterial collective motion, forming coordinated swarms that can increase antibiotic resistance and spread infection. The study demonstrates the importance of mucus in facilitating bacterial swarming, which could pave the way for new strategies to combat infections and antibiotic resistance.
Researchers studied shark and skate skin mucus to understand its unique biochemistry. They found a thin, neutral mucus layer with properties similar to human mucus, suggesting potential biomedical applications for wound care and treatment.
A University at Buffalo-led research team has developed molecules that can transport chloride ions across cell membranes, increasing airway surface liquid and restoring normal mucus clearance in cystic fibrosis cells. The synthetic anion binders offer a new potential treatment for the chronic disease.
Researchers found persistent inflammation in intestines of patients 20 years post-radiotherapy, even with targeted treatments. This could lead to chronic symptoms like tenesmus and frequent diarrhea.
A phase 2 study of idrevloride in hypertonic saline has shown significant improvement in lung function for individuals with primary ciliary dyskinesia. The treatment, an epithelial sodium channel blocker, is safe and well-tolerated, offering hope for newly developed treatments for the rare disease.
A study of nearly 20,000 patients found that the color of their phlegm can indicate the degree of inflammation in their lungs and predict future outcomes. Patients with darker green or brown-colored sputum were at a higher risk of exacerbations, hospitalizations, and death.
A new study breaks down the complex structure of snail mucus, revealing three unique types of secretions with different functions. The researchers identified novel proteins, some of which have never been seen before, and found that subtle differences in composition can significantly impact properties.
Researchers at Sahmyook University repurposed meclofenamate to treat abnormal respiratory mucus, reducing mucin secretion and characteristics of respiratory mucus. This study offers an alternative solution for patients with respiratory diseases, saving time and costs compared to conventional drug development strategies.
Researchers found that a triple combination therapy of elexacaftor, tezacaftor, and ivacaftor improves lung function and reduces inflammation in patients with cystic fibrosis. The treatment's positive effects last over 12 months, offering hope for better management of the disease.
A study published in Nature Communications reveals the controlled release of mucins and insulin by cells, with tetraspanin-8 acting as a gatekeeper. The regulated secretion is biphasic, involving rapid and slower releases of granules, which can be targeted to reset deregulated mucin and insulin secretion.
Researchers found that SARS-CoV-2 mRNA vaccination produces a robust immune response in the nasal cavity, with higher levels of antibodies promoting neutralization. The study suggests targeting the S2 region for intranasal vaccines may increase nasal mucosal levels of IgA and viral neutralization.
A retrospective analysis of patient data suggests that targeting mucus plugs in the lungs may help prevent deaths from COPD. The study found that patients with mucus plugs had a higher mortality rate compared to those without, with significant associations across different disease phases.
Researchers have identified a new cell state in embryonic airway development, which may lead to new approaches for treating chronic respiratory diseases. The discovery highlights the crucial role of cellular heterogeneity in shaping airway biology.
The study found that antibiotics slow down biofilm growth and QS molecule production across both strains, with surface type having a significant effect on the non-mucoid strain. The patterned structure was associated with longer latencies before expression of QS molecules were at their peak.
A multicenter study found that patients with cystic fibrosis can safely take a dual combination of CF modulator drugs for four years while maintaining previously achieved clinical improvement. This breakthrough therapy has improved the quality and length of patients' lives, with some even seeing a 15% increase in lung function.
Researchers have developed an inhalable powder called SHIELD that reduces infection in mouse and non-human primate models by reinforcing the body's mucosal layer. The powder is composed of food-grade materials and biodegrades over a 48-hour period, providing protection for up to 8 hours.
Researchers developed a bioactive gel from cow mucus that promotes bone formation and blood vessel growth, potentially replacing traditional bone grafting methods. The gel interacts with the immune system to enhance healing of bone defects.
Researchers have isolated two new bacterial species from patients with inflammatory bowel disease (IBD), which break down the protective mucus layer of the gut. The bacteria, Allobaculum mucilyticum and Allobaculum fili, are highly efficient at degrading intestinal mucus, leading to potent immune responses.
Researchers discovered that brown algae's fucoidan can remove large amounts of carbon dioxide from the global cycle in the long term. The fucoidan is a recalcitrant molecule that does not return to the atmosphere quickly, making the brown algae particularly effective in removing carbon dioxide from the atmosphere.
A study found that acidification of aerosols post-exhalation significantly impacts viral load. Influenza A viruses are inactivated within minutes, while SARS-CoV-2 requires days at typical indoor pH levels.
A new respiratory vaccine has been shown to provide complete protection against lethal SARS-CoV-2 challenge in mice. The vaccine uses a DNA encoding a viral protein and is delivered through the mucous membranes, targeting immune cells in the nose and lungs.
MIT researchers have identified molecules found in mucus that can block cholera infection by interfering with the genes that cause the microbe to switch into a harmful state. The protective molecules, known as glycans, prevent Vibrio cholerae from producing the toxin that usually leads to severe diarrhea.
A new non-hormonal gel blocks sperm by reinforcing cervical mucus barrier, demonstrating high effectiveness in reducing uterine sperm numbers. The gel has shown a 98% average decrease in sperm numbers compared to untreated control animals, making it a promising alternative to existing contraceptives.
Researchers have identified genetic variants associated with natural resistance to SARS-CoV-2, including a gene linked to mucin production. These findings may help develop vaccines and treatments for viral diseases by understanding the mechanisms underlying immune responses.
Researchers at Duke University have developed a new method called 3D Tracking and Imaging Microscopy (3D-TrIm) to capture real-time 3D footage of viruses approaching cells. This technique combines two microscopes in one, allowing scientists to study the early moments before infection begins and how viruses navigate complex barriers.
Researchers identified a specific gut bacterium responsible for antibiotic-induced GVHD after stem cell transplants. A sugar supplement was found to improve gut health by distracting the bacteria from attacking mucin in the intestinal lining, reducing complications such as GVHD.
Researchers at Brigham and Women's Hospital and MIT have developed RoboCap, a robotic capsule that delivers drugs to the gut by clearing mucus and churning to enhance absorption. In preclinical models, RoboCap increased drug permeability by over 10-fold for insulin and vancomycin.
A new drug capsule developed at MIT may be able to replace injections for biologic drugs by tunneling through the mucus barrier in the small intestine. The capsule's robotic cap spins and displaces mucus, allowing drugs to pass into cells lining the intestine.
Researchers identified 15 instances of mucinization, where new mucins emerged from non-mucin proteins by adding repeating sequences. This process transformed the proteins into mucins with gooey consistency, contributing to their various biological functions.
A new study reveals sponges have a unique mechanism to clear their water channels: a sneeze-like process. Sponges release a type of mucus that is consumed by other animals, providing a food source inaccessible to most sea creatures.
Researchers found that sponges release mucus to unclog their internal filter systems, which also serves as a food source for fish. The study published in Current Biology highlights the unique adaptation of sponges to manage their waste and environment.
A study published in Nature Physics reveals that specialized cell movement may explain the progression of cancer and cystic fibrosis. Cells with ruffled edges sense viscosity and adapt to increase their speed, moving faster through mucus than blood. This discovery sheds light on disease mechanisms and potential treatments.
Human cells move faster through thick mucus due to fin-like ruffles on their membranes, which sense viscosity and adapt to fluid thickness. This discovery could lead to improved diagnosis and treatment of lung diseases, including asthma and mucinous cancer.
Researchers have identified glycans in mucus that can prevent Candida albicans from causing infection. These molecules can be used to develop new antifungal medicines or make disease-causing fungus more susceptible to existing drugs.